Last update :
03/05/2024
Anxiolytic   Lorazepam  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Ativan Great Britain, United States of America
Tavor Italy
Temesta Austria, Belgium, France, Netherlands, Switzerland
Stability of mixtures   Injection   Stability of mixtures : Lorazepam     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 0,05 mg/ml
Injection   Lorazepam   
Injection   Granisetron hydrochloride 0,5 mg/ml
20°C-23°C
4 Hour
Protect from light 57
Level of evidence A+
Glass Sodium chloride 0,9% 1 mg/ml
Injection   Lorazepam   
Injection   Fosphenytoin sodium 5 mg/ml
25°C
8 Hour
Not specified 1419
Glass Glucose 5% 0,25 mg/ml
Injection   Lorazepam   
Injection   Palonosetron hydrochloride 25 µg/ml
20°C-25°C
4 Hour
Not specified 1975
Level of evidence A+
Glass Glucose 5% 0,1 mg/ml
Injection   Lorazepam   
Injection   Milrinone lactate 0,2 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,028 mg/ml
Injection   Lorazepam   
Injection   Ondansetron hydrochloride 0,44 mg/ml
Injection   Dexamethasone sodium phosphate 0,28 mg/ml
25°C
24 Hour
Light 25
Polypropylene Sodium chloride 0,9% 0.16 mg/ml
Injection   Lorazepam   
Injection   Dexamethasone sodium phosphate 0.27 mg/ml
Injection   Diphenhydramine hydrochloride 4 mg/ml
25°C
48 Hour
Light 2132
Level of evidence A+

  Mentions Légales